logo
CONTENT TYPES

Figure 1Loading Img

Therapeutic Role of Deep Eutectic Solvents Based on Menthol and Saturated Fatty Acids on Wound Healing

  • Joana M. Silva
    Joana M. Silva
    3B’s Research Group—Biomaterials, Biodegradable and Biomimetic, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Avepark Barco, Guimarães 4805-017, Portugal
    ICVS/3B’s PT Government Associated Laboratory, Braga/Guimarães 4806-909, Portugal
  • Carolina V. Pereira
    Carolina V. Pereira
    Nutraceuticals and Bioactives Process Technology Laboratory, Instituto de Biologia Experimental e Tecnológica, Oeiras 2780-157, Portugal
  • Francisca Mano
    Francisca Mano
    LAQV/REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Caparica 2829-516, Portugal
  • Eduardo Silva
    Eduardo Silva
    3B’s Research Group—Biomaterials, Biodegradable and Biomimetic, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Avepark Barco, Guimarães 4805-017, Portugal
    ICVS/3B’s PT Government Associated Laboratory, Braga/Guimarães 4806-909, Portugal
  • Vânia I. B. Castro
    Vânia I. B. Castro
    3B’s Research Group—Biomaterials, Biodegradable and Biomimetic, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Avepark Barco, Guimarães 4805-017, Portugal
    ICVS/3B’s PT Government Associated Laboratory, Braga/Guimarães 4806-909, Portugal
  • Isabel Sá-Nogueira
    Isabel Sá-Nogueira
    Microbial Genetics Laboratory, UCIBIO/REQUIMTE, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Caparica 2829-516, Portugal
  • Rui L. Reis
    Rui L. Reis
    3B’s Research Group—Biomaterials, Biodegradable and Biomimetic, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Avepark Barco, Guimarães 4805-017, Portugal
    ICVS/3B’s PT Government Associated Laboratory, Braga/Guimarães 4806-909, Portugal
    The Discoveries Centre for Regenerative and Precision Medicine, Headquarters, University of Minho, Avepark Barco, Guimarães 4805-017, Portugal
    More by Rui L. Reis
  • Alexandre Paiva
    Alexandre Paiva
    LAQV/REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Caparica 2829-516, Portugal
  • Ana A. Matias
    Ana A. Matias
    Nutraceuticals and Bioactives Process Technology Laboratory, Instituto de Biologia Experimental e Tecnológica, Oeiras 2780-157, Portugal
    Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras 2780-157, Portugal
  • , and 
  • Ana Rita C. Duarte*
    Ana Rita C. Duarte
    3B’s Research Group—Biomaterials, Biodegradable and Biomimetic, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Avepark Barco, Guimarães 4805-017, Portugal
    ICVS/3B’s PT Government Associated Laboratory, Braga/Guimarães 4806-909, Portugal
    *E-mail: [email protected]
Cite this: ACS Appl. Bio Mater. 2019, 2, 10, 4346–4355
Publication Date (Web):August 26, 2019
https://doi.org/10.1021/acsabm.9b00598
Copyright © 2019 American Chemical Society
Authors ChoiceACS AuthorChoice
Article Views
653
Altmetric
-
Citations
LEARN ABOUT THESE METRICS

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.

PDF (7 MB)

Abstract

The breakthroughs achieved in green solvents promote the emergence of therapeutic deep eutectic solvents (THEDES), which possess intriguing possible applications in the biomedical field. Herein, the main aim was to unravel the biomedical potential of hydrophobic THEDES based in menthol and saturated fatty acids with different chain lengths (e.g., stearic acid (SA), myristic acid (MA), and lauric acid (LA)). Our comprehensive strategy resulted in the thermophysical characterization of different formulations, which allow one to identify the most suitable molar ratio, as well as the intermolecular interactions behind the successful formation of THEDES. The evaluation of their biological performance was also performed toward bacteria and HaCaT cells. Among the different formulations of THEDES, the one based on menthol and SA establishes stronger hydrogen bonding interactions, being also the most promising formulation because it did not elicit any relevant cytotoxicity, and potentiated wound healing, while presenting antibacterial properties against Staphylococcus epidermis and Staphylococcus aureus strains, some of which were methicillin resistant. This work provides clues on the future use of THEDES based on menthol:SA in wound dressings.

Introduction

ARTICLE SECTIONS
Jump To

Introduced by Abbot and co-workers in a pioneering work, the interest in deep eutectic solvents (DES) has risen over the past decade due to their unique and attractive properties.(1−3) DES can easily be obtained by mixing at certain molar ratios the counterparts, which by self-association lead to a eutectic mixture with the lowest melting point when compared with the counterparts.(3−5) The depression on the melting point can be ascribed to hydrogen bond interactions between the hydrogen bond pairs.(1,2,6) Among the remarkable properties of DES are their low preparation costs, straightforward and green synthesis, no need of postsynthesis purification, environmental disposal, nonflammability, broad range of polarity, low volatility, dipolar nature, chemical and thermal stability, water compatibility, biodegradability, and negligible toxicity profiles.(6−9) Although DES present core characteristics similar to their analogues ionic liquids (ILs), DES fully represent the green chemistry metrics, which makes them highly desirable and a promising alternative to their former solvents.(1,6,7) One of the most attractive features of DES is the large numbers of possible combinations, up to 106, that turn them into an environmentally friendly designer solvent. The tailoring of DES properties can be performed by changing the hydrogen bond pairs, molar ratio, polarizability, temperature, and water content.(10−13)
DES have claimed attention in several fields, such as in organic synthesis, separation processes, biocatalysis, nanomaterials, electrochemistry, polymer fabrication, CO2 capture, foods, cosmetics, pharmaceutics, and biomedical applications.(14−17) In biomedical applications, DES can be used to improve solubility, permeation, and absorption of active pharmaceutical ingredients (APIs).(18−22) The APIs can be used as a DES counterpart, being hence called therapeutic deep eutectic systems (THEDES).(6,19,23) Herein, insights on therapeutic effects of the THEDES based on menthol and different saturated fatty acids will be addressed. Even though the THEDES herein reported have been mentioned in previously published works,(11,24) their biological and pharmaceutical activity was not evaluated and their use in biomedical applications not explored. Menthol is a terpene that can been extracted from Mentha species, and it has been already used for THEDES preparation in combination with a wide range of compounds including ibuprofen, lidocaine, fluconazole, and captopril, among others.(19,23−26) In this work, it was mostly used due to their effectiveness as permeation enhancer together with their well-known anti-inflammatory and antimicrobial properties.(27−29) On the other side, fatty acids are commonly extracted from vegetal and animal fats and their potent antimicrobial properties have been extensively reported, including their important role of self-disinfection power of human skin.(30−32) The preparation of THEDES from fatty acid blends was reported by Silva and co-workers, who evaluated the biological performance of the systems, namely the antimicrobial activity and the possibility to prepare gauzes loaded with the blend.(33) Thereby, our interests have mainly focused on the study of the physicochemical and biological activity of THEDES based on menthol and fatty acids. This study will provide clues and relevant information on the thermophysical properties of these THEDES as well as on their potential use for therapeutic purposes, namely, in wound treatment.

Materials and Methods

ARTICLE SECTIONS
Jump To

THEDES Production and Characterization

During the preparation of the THEDES, menthol (Sigma-Aldrich, ref M2772) was mixed with different saturated fatty acids, including lauric acid (LA; Sigma-Aldrich, ref. W261408-SAMPLE-K), stearic acid (SA; Sigma-Aldrich, ref 175366), and myristic acid (MA; Sigma-Aldrich, ref. 70082). The systems were constantly stirred and heated to 70 °C during 30 min, until formation of a clear liquid solution. Optical characterization of different formulations of THEDES was carried out at room temperature (RT) by polarized optical microscopy (POM), as elsewhere reported.(20,33) The viscosity was measured under controlled stress (shear rate, 10 s–1) using a Kinexus Prot rheometer (Malvern, MaL 1097376). A temperature scan was performed from 50 to 15 °C, adapting previous methodology in the literature.(20,33) The differential scanning calorimetry (DSC; thermal analysis and analyzers) experiments of the powders and THEDES were also performed. The formulations were equilibrated at 40 °C, followed by cooling to −40 °C, an isothermal period of 5 min, and a heating to 100 °C at 5 °C/min. NMR experiments were recorded when the systems were in equilibrium, and no further change in their properties were observed, as elsewhere reported.(34)

Assessment of Cytotoxicity

HaCaT cell line (German Cancer Research Center (DKFZ), Germany) was cultured according to the manufacturer’s instructions in supplemented Dulbecco’s modified Eagle’s medium (Sigma-Aldrich). The assay was made using confluent and differentiated HaCaT cells, which represent 80% epidermal cells. HaCaT cells were seeded at a density of 4.5 × 104 cells/well and allowed to grow during 72 h. The cytotoxic effect of the individual counterparts and THEDES was performed by analyzing the effects of each formulation extract on the cellular metabolism, as established in ISO/EN 10993 and usually performed with THEDES.(20,33−35) The extracts were prepared by overnight incubation of THEDES and powders at concentrations ranging from 0 to 32 mM. Then, cells were washed and cell viability was assessed using MTS colorimetric assay, cell viability being expressed in terms of percentage of living cells relative to the control. The half-maximal effective concentration (EC50) was also obtained using best-fitted trend lines.

Wound Healing Assay

HaCaT cells were seeded cells at a density of 1 × 105 cell/cm2 in a 12-well plate and allowed to grow until 100% confluence (48 h). Afterward, the wound was formed with a 200 μL pipet tip and each well washed twice with warm PBS in order to remove the nonadherent cells. Then, menthol:SA (8:1), menthol, and SA were incubated for 24 h. Micrographs were taken by optic microscopy (Leica DM6000, Germany) at two different time points: 0 and 24 h. Image analysis was performed using ImageJ software and the wound area measured between borderlines. The wound area recovered was expressed in terms of percentage with the following equation using six isolated experiments performed in duplicate:

Antibacterial Assay

THEDES antimicrobial activity was tested by applying the agar diffusion assay. The antibacterial activity of eutectic blends was determined using Staphylococcus aureus (S. aureus) ATCC 25923 and ATCC 700698 (methicillin-resistant strain), S. epidermis ATCC 35984 (methicillin-resistant strain), Pseudomonas aeruginosa (P. aeruginosa) ATCC 27853, and Escherichia coli (E. coli) ATCC 25922, according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI), adapting a methodology previously reported(33) with slight modifications, namely, the use of DMSO at 1% (v/v) concentration to help solubilize the compounds without affecting microbial growth significantly. Furthermore, due to the inherent volatility of menthol for MIC/MBC determination instead of the traditional 96-well plate, microtubes were used and volumes up-scaled accordingly (500 μL of formulations + 500 μL of bacterial suspension) for optimal conditions.

Statistical Analysis

The data were expressed as mean ± standard errors (SD). GraphPad Prism 6 software was used to calculate EC50 values and to analyze significant differences between data sets through one-way analysis of variance (ANOVA) followed by Tukey post hoc test. A p-value < 0.05 was considered significant.

Results and Discussion

ARTICLE SECTIONS
Jump To

THEDES Production and Characterization

In this work, THEDES were prepared from readily available materials, such as menthol and saturated fatty acids. Different molar ratios of the compounds in their solid state have been prepared, by simple mixing of the constituents at either equimolar or imbalanced ratios (Table 1). The liquid phase is dependent on several factors, including the chemical nature of the counterparts and also the molar ratio used, which impair the eutectic point.(36) The eutectic point is the point in the phase diagram with the lowest melting when compared with the counterparts.(2,37) Thereby, DSC analysis was also performed to assess thermal events (Figure 1), namely, the variations on the melting point of THEDES when compared with the parent species, as a depression on the melting point of counterparts is a strong indicator of the successful formation of THEDES. The thermogram of racemic menthol presents two melting points at ≈28 and ≈33 °C, which have been ascribed to α and β polymorphs and is in good agreement with previous reported data.(24,38,39) In the thermogram of each saturated fatty acid a well-defined and sharp endothermic peak was obtained at ≈46.6, ≈58.6, and ≈73 °C, for LA, MA, and SA, respectively. The thermograms of the individual starting materials corroborated previous data in the literature.(24,38−41)
Table 1. Different THEDES Formulations, Their Respective Visual Aspects, and POM Micrographsa
a

The scale bar is 200 μm.

Figure 1

Figure 1. DSC thermograms obtained for powders (A) and THEDES, including menthol:LA (B) menthol:MA (C) and menthol:SA (D). Peaks arising above the baseline represent endothermic peaks.

The peaks obtained in THEDES are different from the ones of the parent species, which further suggests the supramolecular rearrangement while the compounds are in THEDES form. Additionally, a clear depression on the melting point of the parent species can be observed. The thermograms of THEDES indicate that the molar ratio strongly affects the intensity and shift of the peaks, which was previously reported for other THEDES.(20,26,42,43) The DSC data together with POM were both used as easily accessible tools to assess the potential of particular molar ratios to originate THEDES. After this initial assessment, menthol was combined with LA, MA, and SA at 4:1, 8:1, and 8:1, respectively. In each case, a full black background was obtained and a thermogram with an endothermic peak was also achieved.
The establishment of hydrogen bonding between each parent species was then assessed by using NMR spectroscopy. NMR is commonly used to elucidate the types of interactions, as well as the atoms of each counterpart involved, allowing one to get insights into the hydrogen bonding network.(10,44) In Figures 2 and 3, the 1 H NMR spectra of powders and THEDES are presented, as well as the integrals of different signals.

Figure 2

Figure 2. 1H NMR spectra of the powders; (A) menthol, (B) LA, (C) MA, and (D) SA. All of the resonances are attributed.

Figure 3

Figure 3. 1H NMR spectra of the THEDES: (A) menthol:LA (4:1), (B) menthol:MA (8:1), and (C) menthol:SA (8:1). All of the resonances are attributed.

One of the differences between the spectrum of powders and the one of THEDES is the chemical signals ascribed to the hydroxyl groups of menthol. The powder spectrum (Figure 2A) of menthol presents a well-defined doublet (δ = 3.9 ppm), whereas in the THEDES spectrum (Figure 3) a larger singlet was obtained, without any further upfield or downfield chemical displacement. Additionally, the other evidence of the establishment of hydrogen bonding is the signal from proton (H9) bonded to the same carbon (C9) of the hydroxyl group from menthol. In the 1H NMR spectrum of the powder, this signal presents -H- resonance at a chemical shift of 3.14–3.22 ppm, being, as expected, a multiplet. However, in the THEDES 1H NMR spectra, besides no detectable shift, the signals are not anymore a well-defined multiplet, which further suggests that the H9 of menthol is affected by hydrogen bond interactions between the parent molecules. The establishment of hydrogen bonding is further proven by the disappearance of the hydroxyl group of saturated fatty acids in the THEDES spectrum comparison, while in the powder’s spectrum of fatty acids the sharp and defined signals were obtained in the expected chemical shift (δ = 11.5–11.8 ppm). Since these systems are viscous, at the bottom of the peaks in NMR spectra the line width is slightly broad due to the inter- and intradipolar interactions. The overall data indicate that the hydrogen bonds are established between the hydroxyl groups from menthol (hydrogen bond donor) and the carboxyl group from saturated fatty acids (hydrogen bond acceptor). The NMR data support the POM and DSC, as an extensive hydrogen bonding network was observed for the evaluated molar ratios.
After this initial screening, the viscosity of the different THEDES was evaluated at constant shear rate and as a function of temperature (Figure 4). As expected, as the temperature increases, the viscosity of the systems decreases, which is in accordance with the Arrhenius equation.(26,43,45) The menthol systems with lower viscosity were the one with LA, followed by those with MA and SA. Thereby, one can conclude that it highly depends on the chain length of saturated fatty acids. In menthol:SA, it was only possible to evaluate the viscosity until 30 °C; at lower temperatures the system is in solid phase, as shown in the DSC thermogram. The higher viscosity of menthol:SA can be attributed to their extensive hydrogen bonding interactions, which corroborated 1H NMR data.

Figure 4

Figure 4. Variation of the shear viscosity of the different formulations of THEDES as a function of the temperature.

The data obtained also corroborated the one in the literature, where the ability to tune the viscosity of THEDES by the nature of starting compounds and temperature has been described.(11,21,46−49) Additionally, the values of viscosity of these THEDES are relatively low, which is a valuable feature as it allows their manipulation and facilitates their potential applications without the need to, for example, add water in the formulations. The tailoring of viscosity of THEDES is recurrently performed by water content, chemical nature, and working temperature.(12,35,48,50−52)
The main advantage of using THEDES concerns in the formation of a supramolecular arrangement established due to intermolecular interactions, including hydrogen bonding interactions and van der Waals ones. Thereby, the solubility of these poorly water-soluble compounds is strongly increased by a phenomenon known as hydrotropy, where hydrotopes are capable of enhancing the solubility of hydrophobic molecules by means other than micellar solubilization.(53−56) This is in fact a major advantage of the THEDES which can be further explored in biomedical/pharmaceutical field.(18−21,23,26,57,58) Thereby, when using a physical mixture of compounds, different behaviors are obtained, as in that situation a simple dissolution of each compound in a certain medium occurred without any supramolecular arrangement of THEDES.

Bioactivity of THEDES

Menthol-based THEDES were initially tested in terms of cytotoxicity effect in order to select the range of concentrations that will be used in further assays. Comparing the effect of isolated compounds, none of the saturated fatty acids showed cytotoxicity in the range of concentration evaluated, as Figure 5 shows. Assessing THEDES cytotoxicity, menthol:LA (4:1) showed higher cytotoxicity with EC50 value of 5.569 ± 0.326 mM of equivalent menthol (Figure 5A). Moreover, this system showed cytotoxicity similar to that of pure menthol. Comparing menthol with other formulations of THEDES (menthol:MA (8:1) and menthol:SA (8:1)), the isolated compound had higher cytotoxic activity (Figure 5B,C). The presence of MA and SA compounds in the systems decreases the cytotoxicity, which further suggests the supramolecular arrangement between both counterparts while in THEDES form. These data corroborated several studies in the literature where it has been reported that hydrogen-bonded supramolecular arrangements established in DES may lead to synergetic or additive effects between the counterparts. .(35,59−62) However, the synergetic/additivity effects may lead in some cases in more or less toxic systems in comparison with their constituents.(13)

Figure 5

Figure 5. Cytotoxic effect of menthol:LA (4:1) (A), menthol:MA (8:1) (B), and menthol:SA (8:1) (C) with use of HaCaT cell model treated for 24 h. Results were expressed relative to the control as mean ± SD of three independent experiments performed in triplicate.

THEDES based on menthol:SA (8:1) present the lowest cytotoxicity, being the system selected to evaluate its wound healing properties. The bioactive properties of fatty acids and menthol have been reported,(63−65) but from the best of our knowledge there is no information while in THEDES form. Three noncytotoxic concentrations of menthol:SA (8:1) were selected, and the ability of HaCaT cells to migrate was assessed using the wound healing assay. As panels A and B of Figure 6 show, the two highest menthol:SA (8:1) concentrations significantly induce cell migration, leading to higher wound enclosure (areas of 66.00 ± 5.92% and 70.50 ± 4.28%) compared to that of the control (53.23 ± 5.35%), representing an increase of nearly 40%. Moreover, isolated menthol and SA did not show a strong effect on cell migration, with the exception of menthol at a concentration of 0.75 mM. The THEDES (0.75 menthol + 0.09 SA mM) were more effective than isolated menthol, which might suggest that the hydrogen bonding interaction of SA with menthol potentiates its activity. Menthol is a terpene highly explored as anti-inflammatory, antiseptic, and antipruritic, therefore having a strong application in skin disorders.(66) These results may reflect the potential bioactive properties of menthol:SA (8:1) over menthol for topical applications by its high capacity of inducing cell migration.

Figure 6

Figure 6. Wound healing assay. (A) Migration assessment of HaCaT cells after the treatment with menthol:SA (8:1) and menthol and SA at 0 and 24 h postscratch. The lines indicated the boundary lines of the scratch at 0 h. (B) Results were expressed in terms of percentage of wound closure relative to the control using the mean ± SD of six independent experiments performed in duplicate.

Antibacterial Properties

After confirming the biological activity of menthol:SA in wound healing by migration of HaCaT cells, the antibacterial properties were screened out against several microorganisms with disk diffusion assay (DDA). The results obtained for each bacteria and compounds are presented in Table 2. For both, the tested THEDES and pure compounds, no significant inhibition halo was observed in either the E. coli or P. aeruginosa strains tested, with instances of deposit being observable in menthol:SA plates which deterred correct assessment of inhibition halo diameter. Nevertheless, since for both isolated menthol and SA no inhibition halo was observable, these strains were deemed resistant. These results are not surprising, as several instances in literature report greater difficulty in dealing with Gram-negative bacteria due to their more complex membrane structure.(31,67,68) Regarding the Gram-positive strains tested, SA showed no apparent inhibition and deposit formation was observed in menthol:SA, once again interfered with correct determination of inhibition halo. However, isolated menthol showed a significant inhibition halo in all cases.
Table 2. Representative Images of Disk Diffusion Assay Plates Obtained for Individual Counterparts, THEDES, and Controlsa
a

Plates are presented by bacterial strains tested.

It should be noted that the lack of antibacterial activity of SA, as well as, the formation of deposit in all cases for menthol:SA is most likely a consequence of this fatty acid’s low solubility and, consequently, low diffusion rate. However, since the major component of the tested THEDES is menthol which showed relevant antibacterial activity in the DDA against the Gram-positive bacteria strains tested, these were subjected to MIC/MBC determination to try and accurately assess THEDES antibacterial potential. According to the performed experiments, menthol has a MIC value for S. aureus of 4 mM. Once again, SA did not show any antibacterial activity, which might be due to its low solubility, which hinders the complete dissolution of the compound in the selected conditions. Except for SA, all compositions demonstrate antimicrobial activity, being more efficient at higher concentrations, as expected. The methicillin-resistant strains tested show greater resilience, having a higher resistance to both menthol and the THEDES than S. aureus ATCC 25923. Nevertheless, MIC/MBC values for the methicillin-resistant strains are still within noncytotoxic values shown to promote wound healing. These results are presented in Table 3.
Table 3. MIC/MBC Values of Individual Counterparts and THEDESa
 MIC (mM)MBC (mM)
microbial strainmentholSAmenthol:SAmentholSAmenthol:SA
S. aureus4ND3.26 + 1.798ND6.52 + 3.58
MRSA8ND6.52 + 3.5816ND13.03 + 7.16
MRSE8ND6.52 + 3.5816ND13.03 + 7.16
a

Results are presented by bacterial strains tested. ND, not dissolved.

A point of note in the results obtained lies in the fact that, in all cases, the MIC/MBC values of menthol:SA match those of its major component menthol. However, as already mentioned previously according to the molar ratio, 1 mol of menthol:SA (8:1) is composed of about 0.82 mol of menthol and 0.18 mol of stearic acid. As such, even though the MIC/MBC values of menthol:SA and menthol overlap, the THEDES effectively contains, in all cases, a lower amount of menthol per defect which strongly suggests a synergistic interaction between menthol and SA that potentiates antibacterial activity, highlighting the advantages of the studied THEDES.

Conclusion

ARTICLE SECTIONS
Jump To

Herein, the potential of THEDES based on menthol and fatty acid were unveiled, starting from comprehensive data on the thermophysical properties of these solvents and going up to their potential therapeutic application. The fundamental knowledge provides clues for a deeper understanding of these solvents, being crucial to understanding their properties at different operating conditions. The fundamental characterization is hence essential for choosing the right system for a certain application. The thermophysical characterization of THEDES was followed by the evaluation of their biological performance in terms of toxicity toward HaCaT cells and also by their antibacterial properties. Remarkably, among the different formulations, menthol:SA was the most promising formulation and the wound healing assay further suggests their ability to promote the migration of HaCaT. Thereby, the generated data in this work will fulfill gaps in the fundamental knowledge and biological performance of the THEDES based on menthol and fatty acids which fasten the pace to predicting their positive effects in biomedical applications. On the whole, we envisage that the present work opens new intriguing possibilities on the use of these THEDES in wound treatments. Additionally, these results emphasize the huge versatility of THEDES as a new approach toward the development of more effective therapies.
Author Present Address

LAQV-REQUIMTE, Chemistry Department, Faculty of Science and Technology, Nova University of Lisbon, 2829-516 Caparica, Portugal.

The authors declare no competing financial interest.

Author Information

ARTICLE SECTIONS
Jump To

  • Corresponding Author
    • Ana Rita C. Duarte - 3B’s Research Group—Biomaterials, Biodegradable and Biomimetic, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Avepark Barco, Guimarães 4805-017, Portugal; ICVS/3B’s PT Government Associated Laboratory, Braga/Guimarães 4806-909, Portugal; Present Address: LAQV-REQUIMTE, Chemistry Department, Faculty of Science and Technology, Nova University of Lisbon, 2829-516 Caparica, Portugal; Orcidhttp://orcid.org/0000-0003-0800-0112; Email: [email protected]
  • Authors
    • Joana M. Silva - 3B’s Research Group—Biomaterials, Biodegradable and Biomimetic, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Avepark Barco, Guimarães 4805-017, Portugal; ICVS/3B’s PT Government Associated Laboratory, Braga/Guimarães 4806-909, Portugal
    • Carolina V. Pereira - Nutraceuticals and Bioactives Process Technology Laboratory, Instituto de Biologia Experimental e Tecnológica, Oeiras 2780-157, Portugal
    • Francisca Mano - LAQV/REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Caparica 2829-516, Portugal
    • Eduardo Silva - 3B’s Research Group—Biomaterials, Biodegradable and Biomimetic, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Avepark Barco, Guimarães 4805-017, Portugal; ICVS/3B’s PT Government Associated Laboratory, Braga/Guimarães 4806-909, Portugal
    • Vânia I. B. Castro - 3B’s Research Group—Biomaterials, Biodegradable and Biomimetic, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Avepark Barco, Guimarães 4805-017, Portugal; ICVS/3B’s PT Government Associated Laboratory, Braga/Guimarães 4806-909, Portugal
    • Isabel Sá-Nogueira - Microbial Genetics Laboratory, UCIBIO/REQUIMTE, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Caparica 2829-516, Portugal
    • Rui L. Reis - 3B’s Research Group—Biomaterials, Biodegradable and Biomimetic, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Avepark Barco, Guimarães 4805-017, Portugal; ICVS/3B’s PT Government Associated Laboratory, Braga/Guimarães 4806-909, Portugal; The Discoveries Centre for Regenerative and Precision Medicine, Headquarters, University of Minho, Avepark Barco, Guimarães 4805-017, Portugal
    • Alexandre Paiva - LAQV/REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Caparica 2829-516, Portugal
    • Ana A. Matias - Nutraceuticals and Bioactives Process Technology Laboratory, Instituto de Biologia Experimental e Tecnológica, Oeiras 2780-157, Portugal; Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras 2780-157, Portugal
  • Notes

    The authors declare no competing financial interest.

Acknowledgments

ARTICLE SECTIONS
Jump To

The research leading to these results has received funding from Horizon 2020 through ERC-2016-CoG-725034 Des.Solve (ERC Consolidator Grant). We also acknowledge the financial support by the Portuguese Foundation for Science and Technology (FCT) through the postdoctoral grant with Reference No. SFRH/BPD/116779/2016, the PTDC/BBB-490 EBB/1676/2014 Project, the PEst-OE/EQB/LA0004/2011 Grant, iNOVA4Health-UID/Multi/04462/2013, IF Starting Grant GRAPHYT (IF/00723/2014), FCT/MCTES (UID/QUI/50006/2019), FCT/MCTES (UID/Multi/04378/2019) and IF Starting Grant IF/01146/2015.

References

ARTICLE SECTIONS
Jump To

This article references 68 other publications.

  1. 1
    Domínguez de María, P. D.; Maugeri, Z. Ionic liquids in biotransformations: from proof-of-concept to emerging deep-eutectic-solvents. Curr. Opin. Chem. Biol. 2011, 15 (2), 220225,  DOI: 10.1016/j.cbpa.2010.11.008
  2. 2
    Smith, E. L.; Abbott, A. P.; Ryder, K. S. Deep eutectic solvents (DESs) and their applications. Chem. Rev. 2014, 114 (21), 1106011082,  DOI: 10.1021/cr300162p
  3. 3
    Tang, B.; Row, K. H. Recent developments in deep eutectic solvents in chemical sciences. Monatsh. Chem. 2013, 144 (10), 14271454,  DOI: 10.1007/s00706-013-1050-3
  4. 4
    Xu, P.; Zheng, G.-W.; Zong, M.-H.; Li, N.; Lou, W.-Y. Recent progress on deep eutectic solvents in biocatalysis. Bioresour. Bioprocess. 2017, 4 (1), 34,  DOI: 10.1186/s40643-017-0165-5
  5. 5
    Zhang, Q.; De Oliveira Vigier, K.; Royer, S.; Jerome, F. Deep eutectic solvents: syntheses, properties and applications. Chem. Soc. Rev. 2012, 41 (21), 71087146,  DOI: 10.1039/c2cs35178a
  6. 6
    Paiva, A.; Craveiro, R.; Aroso, I.; Martins, M.; Reis, R. L.; Duarte, A. R. C. Natural deep eutectic solvents–solvents for the 21st century. ACS Sustainable Chem. Eng. 2014, 2 (5), 10631071,  DOI: 10.1021/sc500096j
  7. 7
    Mbous, Y. P.; Hayyan, M.; Hayyan, A.; Wong, W. F.; Hashim, M. A.; Looi, C. Y. Applications of deep eutectic solvents in biotechnology and bioengineering—promises and challenges. Biotechnol. Adv. 2017, 35 (2), 105134,  DOI: 10.1016/j.biotechadv.2016.11.006
  8. 8
    Mouden, S.; Klinkhamer, P. G.; Choi, Y. H.; Leiss, K. A. Towards eco-friendly crop protection: natural deep eutectic solvents and defensive secondary metabolites. Phytochem. Rev. 2017, 16 (5), 935951,  DOI: 10.1007/s11101-017-9502-8
  9. 9
    Radošević, K.; Ćurko, N.; Gaurina Srček, V.; Cvjetko Bubalo, M.; Tomašević, M.; Kovačević Ganić, K. K.; Radojčić Redovniković, I. R. Natural deep eutectic solvents as beneficial extractants for enhancement of plant extracts bioactivity. LWT-Food Sci. Technol. 2016, 73, 4551,  DOI: 10.1016/j.lwt.2016.05.037
  10. 10
    Florindo, C.; McIntosh, A.; Welton, T.; Branco, L.; Marrucho, I. A closer look into deep eutectic solvents: exploring intermolecular interactions using solvatochromic probes. Phys. Chem. Chem. Phys. 2018, 20 (1), 206213,  DOI: 10.1039/C7CP06471C
  11. 11
    Martins, M. A. R.; Crespo, E. A.; Pontes, P. V.; Silva, L. P.; Bülow, M.; Maximo, G. J.; Batista, E. A. C.; Held, C.; Pinho, S. P.; Coutinho, J. A. Tunable hydrophobic eutectic solvents based on terpenes and monocarboxylic acids. ACS Sustainable Chem. Eng. 2018, 6 (7), 88368846,  DOI: 10.1021/acssuschemeng.8b01203
  12. 12
    Dai, Y.; Witkamp, G.-J.; Verpoorte, R.; Choi, Y. H. Tailoring properties of natural deep eutectic solvents with water to facilitate their applications. Food Chem. 2015, 187, 1419,  DOI: 10.1016/j.foodchem.2015.03.123
  13. 13
    van Osch, D. J.; Zubeir, L. F.; van den Bruinhorst, A.; Rocha, M. A.; Kroon, M. C. Hydrophobic deep eutectic solvents as water-immiscible extractants. Green Chem. 2015, 17 (9), 45184521,  DOI: 10.1039/C5GC01451D
  14. 14
    Abo-Hamad, A.; Hayyan, M.; AlSaadi, M. A.; Hashim, M. A. Potential applications of deep eutectic solvents in nanotechnology. Chem. Eng. J. 2015, 273, 551567,  DOI: 10.1016/j.cej.2015.03.091
  15. 15
    Alonso, D. A.; Baeza, A.; Chinchilla, R.; Guillena, G.; Pastor, I. M.; Ramón, D. J. Deep eutectic solvents: the organic reaction medium of the century. Eur. J. Org. Chem. 2016, 2016 (4), 612632,  DOI: 10.1002/ejoc.201501197
  16. 16
    Dai, Y.; van Spronsen, J.; Witkamp, G.-J.; Verpoorte, R.; Choi, Y. H. Natural deep eutectic solvents as new potential media for green technology. Anal. Chim. Acta 2013, 766, 6168,  DOI: 10.1016/j.aca.2012.12.019
  17. 17
    Tang, B.; Zhang, H.; Row, K. H. Application of deep eutectic solvents in the extraction and separation of target compounds from various samples. J. Sep. Sci. 2015, 38 (6), 10531064,  DOI: 10.1002/jssc.201401347
  18. 18
    Stott, P. W.; Williams, A. C.; Barry, B. W. Transdermal delivery from eutectic systems: enhanced permeation of a model drug, ibuprofen. J. Controlled Release 1998, 50 (1–3), 297308,  DOI: 10.1016/S0168-3659(97)00153-3
  19. 19
    Duarte, A. R. C.; Ferreira, A. S. D.; Barreiros, S.; Cabrita, E.; Reis, R. L.; Paiva, A. A comparison between pure active pharmaceutical ingredients and therapeutic deep eutectic solvents: Solubility and permeability studies. Eur. J. Pharm. Biopharm. 2017, 114, 296304,  DOI: 10.1016/j.ejpb.2017.02.003
  20. 20
    Silva, J. M.; Reis, R. L.; Paiva, A.; Duarte, A. R. C. Design of functional therapeutic deep eutectic solvents based on choline chloride and ascorbic acid. ACS Sustainable Chem. Eng. 2018, 6 (8), 1035510363,  DOI: 10.1021/acssuschemeng.8b01687
  21. 21
    Morrison, H. G.; Sun, C. C.; Neervannan, S. Characterization of thermal behavior of deep eutectic solvents and their potential as drug solubilization vehicles. Int. J. Pharm. 2009, 378 (1–2), 136139,  DOI: 10.1016/j.ijpharm.2009.05.039
  22. 22
    Santos, F.; P. S. Leitão, M.; C. Duarte, A. Properties of Therapeutic Deep Eutectic Solvents of L-Arginine and Ethambutol for Tuberculosis Treatment. Molecules 2019, 24 (55), 55,  DOI: 10.3390/molecules24010055
  23. 23
    Aroso, I. M.; Craveiro, R.; Rocha, Â.; Dionísio, M.; Barreiros, S.; Reis, R. L.; Paiva, A.; Duarte, A. R. C. Design of controlled release systems for THEDES—therapeutic deep eutectic solvents, using supercritical fluid technology. Int. J. Pharm. 2015, 492 (1–2), 7379,  DOI: 10.1016/j.ijpharm.2015.06.038
  24. 24
    Ribeiro, B. D.; Florindo, C.; Iff, L. C.; Coelho, M. A.; Marrucho, I. M. Menthol-based eutectic mixtures: hydrophobic low viscosity solvents. ACS Sustainable Chem. Eng. 2015, 3 (10), 24692477,  DOI: 10.1021/acssuschemeng.5b00532
  25. 25
    Jeevan, R.; Venkat, R.; Khan, M. A.; Kunta; Goskonda; Brotherton, H. O.; Reddy, I. K. Effect of menthol and related terpenes on the percutaneous absorption of propranolol across excised hairless mouse skin. J. Pharm. Sci. 1997, 86 (12), 13691373,  DOI: 10.1021/js970161+
  26. 26
    Aroso, I. M.; Silva, J. C.; Mano, F.; Ferreira, A. S.; Dionísio, M.; Sá-Nogueira, I.; Barreiros, S.; Reis, R. L.; Paiva, A.; Duarte, A. R. C. Dissolution enhancement of active pharmaceutical ingredients by therapeutic deep eutectic systems. Eur. J. Pharm. Biopharm. 2016, 98, 5766,  DOI: 10.1016/j.ejpb.2015.11.002
  27. 27
    Juergens, U.; Stöber, M.; Vetter, H. The anti-inflammatory activity of L-menthol compared to mint oil in human monocytes in vitro: a novel perspective for its therapeutic use in inflammatory diseases. Eur. J. Med. Res. 1998, 3 (12), 539545
  28. 28
    Patel, T.; Ishiuji, Y.; Yosipovitch, G. Menthol: a refreshing look at this ancient compound. J. Am. Acad. Dermatol. 2007, 57 (5), 873878,  DOI: 10.1016/j.jaad.2007.04.008
  29. 29
    Tsuk, A. G. Menthol enhancement of transdermal drug delivery. U.S. Pat. Appl. US 07/031,077, 1990.
  30. 30
    Nakatsuji, T.; Kao, M. C.; Fang, J.-Y.; Zouboulis, C. C.; Zhang, L.; Gallo, R. L.; Huang, C.-M. Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J. Invest. Dermatol. 2009, 129 (10), 24802488,  DOI: 10.1038/jid.2009.93
  31. 31
    McGaw, L.; Jäger, A.; Van Staden, J.; Houghton, P. Antibacterial effects of fatty acids and related compounds from plants. S. Afr. J. Bot. 2002, 68 (4), 417423,  DOI: 10.1016/S0254-6299(15)30367-7
  32. 32
    Desbois, A. P.; Smith, V. J. Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential. Appl. Microbiol. Biotechnol. 2010, 85 (6), 16291642,  DOI: 10.1007/s00253-009-2355-3
  33. 33
    Silva, J. M.; Akkache, S.; Araújo, A. C.; Masmoudi, Y.; Reis, R. L.; Badens, E.; Duarte, A. R. C. Development of innovative medical devices by dispersing fatty acid eutectic blend on gauzes using supercritical particle generation processes. Mater. Sci. Eng., C 2019, 99, 599610,  DOI: 10.1016/j.msec.2019.02.012
  34. 34
    Castro, V. I.; Craveiro, R.; Silva, J. M.; Reis, R. L.; Paiva, A.; C. Duarte, A. R. Natural deep eutectic systems as alternative nontoxic cryoprotective agents. Cryobiology 2018, 83, 1526,  DOI: 10.1016/j.cryobiol.2018.06.010
  35. 35
    Hayyan, M.; Looi, C. Y.; Hayyan, A.; Wong, W. F.; Hashim, M. A. In vitro and in vivo toxicity profiling of ammonium-based deep eutectic solvents. PLoS One 2015, 10 (2), e0117934  DOI: 10.1371/journal.pone.0117934
  36. 36
    Parnham, E. R.; Drylie, E. A.; Wheatley, P. S.; Slawin, A. M.; Morris, R. E. Ionothermal materials synthesis using unstable deep-eutectic solvents as template-delivery agents. Angew. Chem. 2006, 118 (30), 50845088,  DOI: 10.1002/ange.200600290
  37. 37
    Abbott, A. P.; Capper, G.; Gray, S. Design of improved deep eutectic solvents using hole theory. ChemPhysChem 2006, 7 (4), 803806,  DOI: 10.1002/cphc.200500489
  38. 38
    Corvis, Y.; Négrier, P.; Massip, S.; Leger, J.-M.; Espeau, P. Insights into the crystal structure, polymorphism and thermal behavior of menthol optical isomers and racemates. CrystEngComm 2012, 14 (20), 70557064,  DOI: 10.1039/c2ce26025e
  39. 39
    Corvis, Y.; Wurm, A.; Schick, C.; Espeau, P. New menthol polymorphs identified by flash scanning calorimetry. CrystEngComm 2015, 17 (29), 53575359,  DOI: 10.1039/C5CE00697J
  40. 40
    Wang, L.; Meng, D. Fatty acid eutectic/polymethyl methacrylate composite as form-stable phase change material for thermal energy storage. Appl. Energy 2010, 87 (8), 26602665,  DOI: 10.1016/j.apenergy.2010.01.010
  41. 41
    Yuan, Y.; Zhang, N.; Tao, W.; Cao, X.; He, Y. Fatty acids as phase change materials: a review. Renewable Sustainable Energy Rev. 2014, 29, 482498,  DOI: 10.1016/j.rser.2013.08.107
  42. 42
    Castro, V. n. I.; Mano, F.; Reis, R. L.; Paiva, A.; Duarte, A. R. C. Synthesis and Physical and Thermodynamic Properties of Lactic Acid and Malic Acid-Based Natural Deep Eutectic Solvents. J. Chem. Eng. Data 2018, 63 (7), 25482556,  DOI: 10.1021/acs.jced.7b01037
  43. 43
    Craveiro, R.; Aroso, I.; Flammia, V.; Carvalho, T.; Viciosa, M.; Dionísio, M.; Barreiros, S.; Reis, R.; Duarte, A. R. C.; Paiva, A. Properties and thermal behavior of natural deep eutectic solvents. J. Mol. Liq. 2016, 215, 534540,  DOI: 10.1016/j.molliq.2016.01.038
  44. 44
    D’Agostino, C.; Harris, R. C.; Abbott, A. P.; Gladden, L. F.; Mantle, M. D. Molecular motion and ion diffusion in choline chloride based deep eutectic solvents studied by 1 H pulsed field gradient NMR spectroscopy. Phys. Chem. Chem. Phys. 2011, 13 (48), 2138321391,  DOI: 10.1039/c1cp22554e
  45. 45
    Aroso, I. M.; Paiva, A.; Reis, R. L.; Duarte, A. R. C. Natural deep eutectic solvents from choline chloride and betaine–Physicochemical properties. J. Mol. Liq. 2017, 241, 654661,  DOI: 10.1016/j.molliq.2017.06.051
  46. 46
    Passos, H.; Tavares, D. J.; Ferreira, A. M.; Freire, M. G.; Coutinho, J. o. A. Are aqueous biphasic systems composed of deep eutectic solvents ternary or quaternary systems?. ACS Sustainable Chem. Eng. 2016, 4 (5), 28812886,  DOI: 10.1021/acssuschemeng.6b00485
  47. 47
    Yadav, A.; Pandey, S. Densities and viscosities of (choline chloride+ urea) deep eutectic solvent and its aqueous mixtures in the temperature range 293.15 to 363.15 K. J. Chem. Eng. Data 2014, 59 (7), 22212229,  DOI: 10.1021/je5001796
  48. 48
    Abbott, A. P.; Ahmed, E. I.; Harris, R. C.; Ryder, K. S. Evaluating water miscible deep eutectic solvents (DESs) and ionic liquids as potential lubricants. Green Chem. 2014, 16 (9), 41564161,  DOI: 10.1039/C4GC00952E
  49. 49
    AlOmar, M. K.; Hayyan, M.; Alsaadi, M. A.; Akib, S.; Hayyan, A.; Hashim, M. A. Glycerol-based deep eutectic solvents: physical properties. J. Mol. Liq. 2016, 215, 98103,  DOI: 10.1016/j.molliq.2015.11.032
  50. 50
    Jeong, K. M.; Lee, M. S.; Nam, M. W.; Zhao, J.; Jin, Y.; Lee, D.-K.; Kwon, S. W.; Jeong, J. H.; Lee, J. Tailoring and recycling of deep eutectic solvents as sustainable and efficient extraction media. Journal of Chromatography A 2015, 1424, 1017,  DOI: 10.1016/j.chroma.2015.10.083
  51. 51
    AlOmar, M. K.; Alsaadi, M. A.; Hayyan, M.; Akib, S.; Ibrahim, R. K.; Hashim, M. A. Lead removal from water by choline chloride based deep eutectic solvents functionalized carbon nanotubes. J. Mol. Liq. 2016, 222, 883894,  DOI: 10.1016/j.molliq.2016.07.074
  52. 52
    Zhekenov, T.; Toksanbayev, N.; Kazakbayeva, Z.; Shah, D.; Mjalli, F. S. Formation of type III Deep Eutectic Solvents and effect of water on their intermolecular interactions. Fluid Phase Equilib. 2017, 441, 4348,  DOI: 10.1016/j.fluid.2017.01.022
  53. 53
    Cláudio, A. F. M.; Neves, M. C.; Shimizu, K.; Canongia Lopes, J. N.; Freire, M. G.; Coutinho, J. A. The magic of aqueous solutions of ionic liquids: ionic liquids as a powerful class of catanionic hydrotropes. Green Chem. 2015, 17, 39483963,  DOI: 10.1039/C5GC00712G
  54. 54
    Cláudio, A. F. M.; Neves, M. C.; Shimizu, K.; Canongia Lopes, J. N.; Freire, M. G.; Coutinho, J. A. The magic of aqueous solutions of ionic liquids: ionic liquids as a powerful class of catanionic hydrotropes. Green Chem. 2015, 17 (7), 39483963,  DOI: 10.1039/C5GC00712G
  55. 55
    Sintra, T. E.; Shimizu, K.; Ventura, S. P.; Shimizu, S.; Canongia Lopes, J. N.; Coutinho, J. A. Enhanced dissolution of ibuprofen using ionic liquids as catanionic hydrotropes. Phys. Chem. Chem. Phys. 2018, 20 (3), 20942103,  DOI: 10.1039/C7CP07569C
  56. 56
    Soares, B.; Tavares, D. J.; Amaral, J. L.; Silvestre, A. J.; Freire, C. S.; Coutinho, J. A. Enhanced solubility of lignin monomeric model compounds and technical lignins in aqueous solutions of deep eutectic solvents. ACS Sustainable Chem. Eng. 2017, 5 (5), 40564065,  DOI: 10.1021/acssuschemeng.7b00053
  57. 57
    Mano, F.; Aroso, I. M.; Barreiros, S.; Borges, J. o. P.; Reis, R. L.; Duarte, A. R. C.; Paiva, A. Production of poly (vinyl alcohol)(PVA) fibers with encapsulated natural deep eutectic solvent (NADES) using electrospinning. ACS Sustainable Chem. Eng. 2015, 3 (10), 25042509,  DOI: 10.1021/acssuschemeng.5b00613
  58. 58
    Yong, C. S.; Jung, S. H.; Rhee, J.-D.; Choi, H.-G.; Lee, B.-J.; Kim, D.-C.; Choi, Y. W.; Kim, C.-K. Improved solubility and in vitro dissolution of Ibuprofen from poloxamer gel using eutectic mixture with menthol. Drug Delivery 2003, 10 (3), 179183,  DOI: 10.1080/713840406
  59. 59
    Hayyan, M.; Mbous, Y. P.; Looi, C. Y.; Wong, W. F.; Hayyan, A.; Salleh, Z.; Mohd-Ali, O. Natural deep eutectic solvents: cytotoxic profile. SpringerPlus 2016, 5 (1), 913,  DOI: 10.1186/s40064-016-2575-9
  60. 60
    Juneidi, I.; Hayyan, M.; Hashim, M. A. Evaluation of toxicity and biodegradability for cholinium-based deep eutectic solvents. RSC Adv. 2015, 5 (102), 8363683647,  DOI: 10.1039/C5RA12425E
  61. 61
    Radošević, K.; Cvjetko Bubalo, M. C.; Gaurina Srček, V. G.; Grgas, D.; Landeka Dragičević, T. L.; Radojčić Redovniković, I. R. Evaluation of toxicity and biodegradability of choline chloride based deep eutectic solvents. Ecotoxicol. Environ. Saf. 2015, 112, 4653,  DOI: 10.1016/j.ecoenv.2014.09.034
  62. 62
    Radošević, K.; Ćanak, I.; Panić, M.; Markov, K.; Bubalo, M. C.; Frece, J.; Srček, V. G.; Redovniković, I. R. Antimicrobial, cytotoxic and antioxidative evaluation of natural deep eutectic solvents. Environ. Sci. Pollut. Res. 2018, 25 (14), 1418814196,  DOI: 10.1007/s11356-018-1669-z
  63. 63
    Hou, C. T. New bioactive fatty acids. Asia Pac. J. Clin. Nutr. 2008, 17 (S1), 192195
  64. 64
    McKay, D. L.; Blumberg, J. B. A review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L.). Phytother. Res. 2006, 20 (8), 619633,  DOI: 10.1002/ptr.1936
  65. 65
    Muniyan, R.; Gurunathan, J. Lauric acid and myristic acid from Allium sativum inhibit the growth of Mycobacterium tuberculosis H37Ra: in silico analysis reveals possible binding to protein kinase B. Pharm. Biol. 2016, 54 (12), 28142821,  DOI: 10.1080/13880209.2016.1184691
  66. 66
    Barros, A. A.; Silva, J. M.; Craveiro, R.; Paiva, A.; Reis, R. L.; Duarte, A. R. C. Green solvents for enhanced impregnation processes in biomedicine. Current Opinion in Green and Sustainable Chemistry 2017, 5, 8287,  DOI: 10.1016/j.cogsc.2017.03.014
  67. 67
    Kitahara, T.; Koyama, N.; Matsuda, J.; Aoyama, Y.; Hirakata, Y.; Kamihira, S.; Kohno, S.; Nakashima, M.; Sasaki, H. Antimicrobial activity of saturated fatty acids and fatty amines against methicillin-resistant Staphylococcus aureus. Biol. Pharm. Bull. 2004, 27 (9), 13211326,  DOI: 10.1248/bpb.27.1321
  68. 68
    Ouattara, B.; Simard, R. E.; Holley, R. A.; Piette, G. J.-P.; Bégin, A. Antibacterial activity of selected fatty acids and essential oils against six meat spoilage organisms. Int. J. Food Microbiol. 1997, 37 (2–3), 155162,  DOI: 10.1016/S0168-1605(97)00070-6

Cited By


This article is cited by 8 publications.

  1. Dannie J. G. P. van Osch, Carin H. J. T. Dietz, Samah E. E. Warrag, Maaike C. Kroon. The Curious Case of Hydrophobic Deep Eutectic Solvents: A Story on the Discovery, Design, and Applications. ACS Sustainable Chemistry & Engineering 2020, 8 (29) , 10591-10612. https://doi.org/10.1021/acssuschemeng.0c00559
  2. Liliana A. Rodrigues, Carolina V. Pereira, Inês C. Leonardo, Naiara Fernández, Frédéric B. Gaspar, Joana M. Silva, Rui L. Reis, Ana Rita C. Duarte, Alexandre Paiva, Ana A. Matias. Terpene-Based Natural Deep Eutectic Systems as Efficient Solvents To Recover Astaxanthin from Brown Crab Shell Residues. ACS Sustainable Chemistry & Engineering 2020, 8 (5) , 2246-2259. https://doi.org/10.1021/acssuschemeng.9b06283
  3. Filipa Santos, Ana Rita C. Duarte. Therapeutic Deep Eutectic Systems for the Enhancement of Drug Bioavailability. 2021,,, 103-129. https://doi.org/10.1007/978-3-030-53069-3_3
  4. Faisal Al-Akayleh, Samer Adwan, Mai Khanfar, Nasir Idkaidek, Mayyas Al-Remawi. A Novel Eutectic-Based Transdermal Delivery System for Risperidone. AAPS PharmSciTech 2021, 22 (1) https://doi.org/10.1208/s12249-020-01844-4
  5. Cristian Grazioli, Georgina Faura, Nicolò Dossi, Rosanna Toniolo, Franco Tubaro, Fabio Terzi, Gino Bontempelli. A colorimetric paper-based smart label soaked with a deep-eutectic solvent for the detection of malondialdehyde. Sensors and Actuators B: Chemical 2020, , 129174. https://doi.org/10.1016/j.snb.2020.129174
  6. Eduardo Silva, Filipe Oliveira, Joana M. Silva, Ana Matias, Rui L. Reis, Ana Rita C. Duarte. Optimal Design of THEDES Based on Perillyl Alcohol and Ibuprofen. Pharmaceutics 2020, 12 (11) , 1121. https://doi.org/10.3390/pharmaceutics12111121
  7. Filipe Silva Nunes de Oliveira, Ana Rita Cruz Duarte. A look on target-specificity of eutectic systems based on natural bioactive compounds. 2020,,https://doi.org/10.1016/bs.abr.2020.09.008
  8. Joana M. Silva, Eduardo Silva, Rui L. Reis, Ana Rita C. Duarte. A closer look in the antimicrobial properties of deep eutectic solvents based on fatty acids. Sustainable Chemistry and Pharmacy 2019, 14 , 100192. https://doi.org/10.1016/j.scp.2019.100192
  • Abstract

    Figure 1

    Figure 1. DSC thermograms obtained for powders (A) and THEDES, including menthol:LA (B) menthol:MA (C) and menthol:SA (D). Peaks arising above the baseline represent endothermic peaks.

    Figure 2

    Figure 2. 1H NMR spectra of the powders; (A) menthol, (B) LA, (C) MA, and (D) SA. All of the resonances are attributed.

    Figure 3

    Figure 3. 1H NMR spectra of the THEDES: (A) menthol:LA (4:1), (B) menthol:MA (8:1), and (C) menthol:SA (8:1). All of the resonances are attributed.

    Figure 4

    Figure 4. Variation of the shear viscosity of the different formulations of THEDES as a function of the temperature.

    Figure 5

    Figure 5. Cytotoxic effect of menthol:LA (4:1) (A), menthol:MA (8:1) (B), and menthol:SA (8:1) (C) with use of HaCaT cell model treated for 24 h. Results were expressed relative to the control as mean ± SD of three independent experiments performed in triplicate.

    Figure 6

    Figure 6. Wound healing assay. (A) Migration assessment of HaCaT cells after the treatment with menthol:SA (8:1) and menthol and SA at 0 and 24 h postscratch. The lines indicated the boundary lines of the scratch at 0 h. (B) Results were expressed in terms of percentage of wound closure relative to the control using the mean ± SD of six independent experiments performed in duplicate.

  • References

    ARTICLE SECTIONS
    Jump To

    This article references 68 other publications.

    1. 1
      Domínguez de María, P. D.; Maugeri, Z. Ionic liquids in biotransformations: from proof-of-concept to emerging deep-eutectic-solvents. Curr. Opin. Chem. Biol. 2011, 15 (2), 220225,  DOI: 10.1016/j.cbpa.2010.11.008
    2. 2
      Smith, E. L.; Abbott, A. P.; Ryder, K. S. Deep eutectic solvents (DESs) and their applications. Chem. Rev. 2014, 114 (21), 1106011082,  DOI: 10.1021/cr300162p
    3. 3
      Tang, B.; Row, K. H. Recent developments in deep eutectic solvents in chemical sciences. Monatsh. Chem. 2013, 144 (10), 14271454,  DOI: 10.1007/s00706-013-1050-3
    4. 4
      Xu, P.; Zheng, G.-W.; Zong, M.-H.; Li, N.; Lou, W.-Y. Recent progress on deep eutectic solvents in biocatalysis. Bioresour. Bioprocess. 2017, 4 (1), 34,  DOI: 10.1186/s40643-017-0165-5
    5. 5
      Zhang, Q.; De Oliveira Vigier, K.; Royer, S.; Jerome, F. Deep eutectic solvents: syntheses, properties and applications. Chem. Soc. Rev. 2012, 41 (21), 71087146,  DOI: 10.1039/c2cs35178a
    6. 6
      Paiva, A.; Craveiro, R.; Aroso, I.; Martins, M.; Reis, R. L.; Duarte, A. R. C. Natural deep eutectic solvents–solvents for the 21st century. ACS Sustainable Chem. Eng. 2014, 2 (5), 10631071,  DOI: 10.1021/sc500096j
    7. 7
      Mbous, Y. P.; Hayyan, M.; Hayyan, A.; Wong, W. F.; Hashim, M. A.; Looi, C. Y. Applications of deep eutectic solvents in biotechnology and bioengineering—promises and challenges. Biotechnol. Adv. 2017, 35 (2), 105134,  DOI: 10.1016/j.biotechadv.2016.11.006
    8. 8
      Mouden, S.; Klinkhamer, P. G.; Choi, Y. H.; Leiss, K. A. Towards eco-friendly crop protection: natural deep eutectic solvents and defensive secondary metabolites. Phytochem. Rev. 2017, 16 (5), 935951,  DOI: 10.1007/s11101-017-9502-8
    9. 9
      Radošević, K.; Ćurko, N.; Gaurina Srček, V.; Cvjetko Bubalo, M.; Tomašević, M.; Kovačević Ganić, K. K.; Radojčić Redovniković, I. R. Natural deep eutectic solvents as beneficial extractants for enhancement of plant extracts bioactivity. LWT-Food Sci. Technol. 2016, 73, 4551,  DOI: 10.1016/j.lwt.2016.05.037
    10. 10
      Florindo, C.; McIntosh, A.; Welton, T.; Branco, L.; Marrucho, I. A closer look into deep eutectic solvents: exploring intermolecular interactions using solvatochromic probes. Phys. Chem. Chem. Phys. 2018, 20 (1), 206213,  DOI: 10.1039/C7CP06471C
    11. 11
      Martins, M. A. R.; Crespo, E. A.; Pontes, P. V.; Silva, L. P.; Bülow, M.; Maximo, G. J.; Batista, E. A. C.; Held, C.; Pinho, S. P.; Coutinho, J. A. Tunable hydrophobic eutectic solvents based on terpenes and monocarboxylic acids. ACS Sustainable Chem. Eng. 2018, 6 (7), 88368846,  DOI: 10.1021/acssuschemeng.8b01203
    12. 12
      Dai, Y.; Witkamp, G.-J.; Verpoorte, R.; Choi, Y. H. Tailoring properties of natural deep eutectic solvents with water to facilitate their applications. Food Chem. 2015, 187, 1419,  DOI: 10.1016/j.foodchem.2015.03.123
    13. 13
      van Osch, D. J.; Zubeir, L. F.; van den Bruinhorst, A.; Rocha, M. A.; Kroon, M. C. Hydrophobic deep eutectic solvents as water-immiscible extractants. Green Chem. 2015, 17 (9), 45184521,  DOI: 10.1039/C5GC01451D
    14. 14
      Abo-Hamad, A.; Hayyan, M.; AlSaadi, M. A.; Hashim, M. A. Potential applications of deep eutectic solvents in nanotechnology. Chem. Eng. J. 2015, 273, 551567,  DOI: 10.1016/j.cej.2015.03.091
    15. 15
      Alonso, D. A.; Baeza, A.; Chinchilla, R.; Guillena, G.; Pastor, I. M.; Ramón, D. J. Deep eutectic solvents: the organic reaction medium of the century. Eur. J. Org. Chem. 2016, 2016 (4), 612632,  DOI: 10.1002/ejoc.201501197
    16. 16
      Dai, Y.; van Spronsen, J.; Witkamp, G.-J.; Verpoorte, R.; Choi, Y. H. Natural deep eutectic solvents as new potential media for green technology. Anal. Chim. Acta 2013, 766, 6168,  DOI: 10.1016/j.aca.2012.12.019
    17. 17
      Tang, B.; Zhang, H.; Row, K. H. Application of deep eutectic solvents in the extraction and separation of target compounds from various samples. J. Sep. Sci. 2015, 38 (6), 10531064,  DOI: 10.1002/jssc.201401347
    18. 18
      Stott, P. W.; Williams, A. C.; Barry, B. W. Transdermal delivery from eutectic systems: enhanced permeation of a model drug, ibuprofen. J. Controlled Release 1998, 50 (1–3), 297308,  DOI: 10.1016/S0168-3659(97)00153-3
    19. 19
      Duarte, A. R. C.; Ferreira, A. S. D.; Barreiros, S.; Cabrita, E.; Reis, R. L.; Paiva, A. A comparison between pure active pharmaceutical ingredients and therapeutic deep eutectic solvents: Solubility and permeability studies. Eur. J. Pharm. Biopharm. 2017, 114, 296304,  DOI: 10.1016/j.ejpb.2017.02.003
    20. 20
      Silva, J. M.; Reis, R. L.; Paiva, A.; Duarte, A. R. C. Design of functional therapeutic deep eutectic solvents based on choline chloride and ascorbic acid. ACS Sustainable Chem. Eng. 2018, 6 (8), 1035510363,  DOI: 10.1021/acssuschemeng.8b01687
    21. 21
      Morrison, H. G.; Sun, C. C.; Neervannan, S. Characterization of thermal behavior of deep eutectic solvents and their potential as drug solubilization vehicles. Int. J. Pharm. 2009, 378 (1–2), 136139,  DOI: 10.1016/j.ijpharm.2009.05.039
    22. 22
      Santos, F.; P. S. Leitão, M.; C. Duarte, A. Properties of Therapeutic Deep Eutectic Solvents of L-Arginine and Ethambutol for Tuberculosis Treatment. Molecules 2019, 24 (55), 55,  DOI: 10.3390/molecules24010055
    23. 23
      Aroso, I. M.; Craveiro, R.; Rocha, Â.; Dionísio, M.; Barreiros, S.; Reis, R. L.; Paiva, A.; Duarte, A. R. C. Design of controlled release systems for THEDES—therapeutic deep eutectic solvents, using supercritical fluid technology. Int. J. Pharm. 2015, 492 (1–2), 7379,  DOI: 10.1016/j.ijpharm.2015.06.038
    24. 24
      Ribeiro, B. D.; Florindo, C.; Iff, L. C.; Coelho, M. A.; Marrucho, I. M. Menthol-based eutectic mixtures: hydrophobic low viscosity solvents. ACS Sustainable Chem. Eng. 2015, 3 (10), 24692477,  DOI: 10.1021/acssuschemeng.5b00532
    25. 25
      Jeevan, R.; Venkat, R.; Khan, M. A.; Kunta; Goskonda; Brotherton, H. O.; Reddy, I. K. Effect of menthol and related terpenes on the percutaneous absorption of propranolol across excised hairless mouse skin. J. Pharm. Sci. 1997, 86 (12), 13691373,  DOI: 10.1021/js970161+
    26. 26
      Aroso, I. M.; Silva, J. C.; Mano, F.; Ferreira, A. S.; Dionísio, M.; Sá-Nogueira, I.; Barreiros, S.; Reis, R. L.; Paiva, A.; Duarte, A. R. C. Dissolution enhancement of active pharmaceutical ingredients by therapeutic deep eutectic systems. Eur. J. Pharm. Biopharm. 2016, 98, 5766,  DOI: 10.1016/j.ejpb.2015.11.002
    27. 27
      Juergens, U.; Stöber, M.; Vetter, H. The anti-inflammatory activity of L-menthol compared to mint oil in human monocytes in vitro: a novel perspective for its therapeutic use in inflammatory diseases. Eur. J. Med. Res. 1998, 3 (12), 539545
    28. 28
      Patel, T.; Ishiuji, Y.; Yosipovitch, G. Menthol: a refreshing look at this ancient compound. J. Am. Acad. Dermatol. 2007, 57 (5), 873878,  DOI: 10.1016/j.jaad.2007.04.008
    29. 29
      Tsuk, A. G. Menthol enhancement of transdermal drug delivery. U.S. Pat. Appl. US 07/031,077, 1990.
    30. 30
      Nakatsuji, T.; Kao, M. C.; Fang, J.-Y.; Zouboulis, C. C.; Zhang, L.; Gallo, R. L.; Huang, C.-M. Antimicrobial property of lauric acid against Propionibacterium acnes: its therapeutic potential for inflammatory acne vulgaris. J. Invest. Dermatol. 2009, 129 (10), 24802488,  DOI: 10.1038/jid.2009.93
    31. 31
      McGaw, L.; Jäger, A.; Van Staden, J.; Houghton, P. Antibacterial effects of fatty acids and related compounds from plants. S. Afr. J. Bot. 2002, 68 (4), 417423,  DOI: 10.1016/S0254-6299(15)30367-7
    32. 32
      Desbois, A. P.; Smith, V. J. Antibacterial free fatty acids: activities, mechanisms of action and biotechnological potential. Appl. Microbiol. Biotechnol. 2010, 85 (6), 16291642,  DOI: 10.1007/s00253-009-2355-3
    33. 33
      Silva, J. M.; Akkache, S.; Araújo, A. C.; Masmoudi, Y.; Reis, R. L.; Badens, E.; Duarte, A. R. C. Development of innovative medical devices by dispersing fatty acid eutectic blend on gauzes using supercritical particle generation processes. Mater. Sci. Eng., C 2019, 99, 599610,  DOI: 10.1016/j.msec.2019.02.012
    34. 34
      Castro, V. I.; Craveiro, R.; Silva, J. M.; Reis, R. L.; Paiva, A.; C. Duarte, A. R. Natural deep eutectic systems as alternative nontoxic cryoprotective agents. Cryobiology 2018, 83, 1526,  DOI: 10.1016/j.cryobiol.2018.06.010
    35. 35
      Hayyan, M.; Looi, C. Y.; Hayyan, A.; Wong, W. F.; Hashim, M. A. In vitro and in vivo toxicity profiling of ammonium-based deep eutectic solvents. PLoS One 2015, 10 (2), e0117934  DOI: 10.1371/journal.pone.0117934
    36. 36
      Parnham, E. R.; Drylie, E. A.; Wheatley, P. S.; Slawin, A. M.; Morris, R. E. Ionothermal materials synthesis using unstable deep-eutectic solvents as template-delivery agents. Angew. Chem. 2006, 118 (30), 50845088,  DOI: 10.1002/ange.200600290
    37. 37
      Abbott, A. P.; Capper, G.; Gray, S. Design of improved deep eutectic solvents using hole theory. ChemPhysChem 2006, 7 (4), 803806,  DOI: 10.1002/cphc.200500489
    38. 38
      Corvis, Y.; Négrier, P.; Massip, S.; Leger, J.-M.; Espeau, P. Insights into the crystal structure, polymorphism and thermal behavior of menthol optical isomers and racemates. CrystEngComm 2012, 14 (20), 70557064,  DOI: 10.1039/c2ce26025e
    39. 39
      Corvis, Y.; Wurm, A.; Schick, C.; Espeau, P. New menthol polymorphs identified by flash scanning calorimetry. CrystEngComm 2015, 17 (29), 53575359,  DOI: 10.1039/C5CE00697J
    40. 40
      Wang, L.; Meng, D. Fatty acid eutectic/polymethyl methacrylate composite as form-stable phase change material for thermal energy storage. Appl. Energy 2010, 87 (8), 26602665,  DOI: 10.1016/j.apenergy.2010.01.010
    41. 41
      Yuan, Y.; Zhang, N.; Tao, W.; Cao, X.; He, Y. Fatty acids as phase change materials: a review. Renewable Sustainable Energy Rev. 2014, 29, 482498,  DOI: 10.1016/j.rser.2013.08.107
    42. 42
      Castro, V. n. I.; Mano, F.; Reis, R. L.; Paiva, A.; Duarte, A. R. C. Synthesis and Physical and Thermodynamic Properties of Lactic Acid and Malic Acid-Based Natural Deep Eutectic Solvents. J. Chem. Eng. Data 2018, 63 (7), 25482556,  DOI: 10.1021/acs.jced.7b01037
    43. 43
      Craveiro, R.; Aroso, I.; Flammia, V.; Carvalho, T.; Viciosa, M.; Dionísio, M.; Barreiros, S.; Reis, R.; Duarte, A. R. C.; Paiva, A. Properties and thermal behavior of natural deep eutectic solvents. J. Mol. Liq. 2016, 215, 534540,  DOI: 10.1016/j.molliq.2016.01.038
    44. 44
      D’Agostino, C.; Harris, R. C.; Abbott, A. P.; Gladden, L. F.; Mantle, M. D. Molecular motion and ion diffusion in choline chloride based deep eutectic solvents studied by 1 H pulsed field gradient NMR spectroscopy. Phys. Chem. Chem. Phys. 2011, 13 (48), 2138321391,  DOI: 10.1039/c1cp22554e
    45. 45
      Aroso, I. M.; Paiva, A.; Reis, R. L.; Duarte, A. R. C. Natural deep eutectic solvents from choline chloride and betaine–Physicochemical properties. J. Mol. Liq. 2017, 241, 654661,  DOI: 10.1016/j.molliq.2017.06.051
    46. 46
      Passos, H.; Tavares, D. J.; Ferreira, A. M.; Freire, M. G.; Coutinho, J. o. A. Are aqueous biphasic systems composed of deep eutectic solvents ternary or quaternary systems?. ACS Sustainable Chem. Eng. 2016, 4 (5), 28812886,  DOI: 10.1021/acssuschemeng.6b00485
    47. 47
      Yadav, A.; Pandey, S. Densities and viscosities of (choline chloride+ urea) deep eutectic solvent and its aqueous mixtures in the temperature range 293.15 to 363.15 K. J. Chem. Eng. Data 2014, 59 (7), 22212229,  DOI: 10.1021/je5001796
    48. 48
      Abbott, A. P.; Ahmed, E. I.; Harris, R. C.; Ryder, K. S. Evaluating water miscible deep eutectic solvents (DESs) and ionic liquids as potential lubricants. Green Chem. 2014, 16 (9), 41564161,  DOI: 10.1039/C4GC00952E
    49. 49
      AlOmar, M. K.; Hayyan, M.; Alsaadi, M. A.; Akib, S.; Hayyan, A.; Hashim, M. A. Glycerol-based deep eutectic solvents: physical properties. J. Mol. Liq. 2016, 215, 98103,  DOI: 10.1016/j.molliq.2015.11.032
    50. 50
      Jeong, K. M.; Lee, M. S.; Nam, M. W.; Zhao, J.; Jin, Y.; Lee, D.-K.; Kwon, S. W.; Jeong, J. H.; Lee, J. Tailoring and recycling of deep eutectic solvents as sustainable and efficient extraction media. Journal of Chromatography A 2015, 1424, 1017,  DOI: 10.1016/j.chroma.2015.10.083
    51. 51
      AlOmar, M. K.; Alsaadi, M. A.; Hayyan, M.; Akib, S.; Ibrahim, R. K.; Hashim, M. A. Lead removal from water by choline chloride based deep eutectic solvents functionalized carbon nanotubes. J. Mol. Liq. 2016, 222, 883894,  DOI: 10.1016/j.molliq.2016.07.074
    52. 52
      Zhekenov, T.; Toksanbayev, N.; Kazakbayeva, Z.; Shah, D.; Mjalli, F. S. Formation of type III Deep Eutectic Solvents and effect of water on their intermolecular interactions. Fluid Phase Equilib. 2017, 441, 4348,  DOI: 10.1016/j.fluid.2017.01.022
    53. 53
      Cláudio, A. F. M.; Neves, M. C.; Shimizu, K.; Canongia Lopes, J. N.; Freire, M. G.; Coutinho, J. A. The magic of aqueous solutions of ionic liquids: ionic liquids as a powerful class of catanionic hydrotropes. Green Chem. 2015, 17, 39483963,  DOI: 10.1039/C5GC00712G
    54. 54
      Cláudio, A. F. M.; Neves, M. C.; Shimizu, K.; Canongia Lopes, J. N.; Freire, M. G.; Coutinho, J. A. The magic of aqueous solutions of ionic liquids: ionic liquids as a powerful class of catanionic hydrotropes. Green Chem. 2015, 17 (7), 39483963,  DOI: 10.1039/C5GC00712G
    55. 55
      Sintra, T. E.; Shimizu, K.; Ventura, S. P.; Shimizu, S.; Canongia Lopes, J. N.; Coutinho, J. A. Enhanced dissolution of ibuprofen using ionic liquids as catanionic hydrotropes. Phys. Chem. Chem. Phys. 2018, 20 (3), 20942103,  DOI: 10.1039/C7CP07569C
    56. 56
      Soares, B.; Tavares, D. J.; Amaral, J. L.; Silvestre, A. J.; Freire, C. S.; Coutinho, J. A. Enhanced solubility of lignin monomeric model compounds and technical lignins in aqueous solutions of deep eutectic solvents. ACS Sustainable Chem. Eng. 2017, 5 (5), 40564065,  DOI: 10.1021/acssuschemeng.7b00053
    57. 57
      Mano, F.; Aroso, I. M.; Barreiros, S.; Borges, J. o. P.; Reis, R. L.; Duarte, A. R. C.; Paiva, A. Production of poly (vinyl alcohol)(PVA) fibers with encapsulated natural deep eutectic solvent (NADES) using electrospinning. ACS Sustainable Chem. Eng. 2015, 3 (10), 25042509,  DOI: 10.1021/acssuschemeng.5b00613
    58. 58
      Yong, C. S.; Jung, S. H.; Rhee, J.-D.; Choi, H.-G.; Lee, B.-J.; Kim, D.-C.; Choi, Y. W.; Kim, C.-K. Improved solubility and in vitro dissolution of Ibuprofen from poloxamer gel using eutectic mixture with menthol. Drug Delivery 2003, 10 (3), 179183,  DOI: 10.1080/713840406
    59. 59
      Hayyan, M.; Mbous, Y. P.; Looi, C. Y.; Wong, W. F.; Hayyan, A.; Salleh, Z.; Mohd-Ali, O. Natural deep eutectic solvents: cytotoxic profile. SpringerPlus 2016, 5 (1), 913,  DOI: 10.1186/s40064-016-2575-9
    60. 60
      Juneidi, I.; Hayyan, M.; Hashim, M. A. Evaluation of toxicity and biodegradability for cholinium-based deep eutectic solvents. RSC Adv. 2015, 5 (102), 8363683647,  DOI: 10.1039/C5RA12425E
    61. 61
      Radošević, K.; Cvjetko Bubalo, M. C.; Gaurina Srček, V. G.; Grgas, D.; Landeka Dragičević, T. L.; Radojčić Redovniković, I. R. Evaluation of toxicity and biodegradability of choline chloride based deep eutectic solvents. Ecotoxicol. Environ. Saf. 2015, 112, 4653,  DOI: 10.1016/j.ecoenv.2014.09.034
    62. 62
      Radošević, K.; Ćanak, I.; Panić, M.; Markov, K.; Bubalo, M. C.; Frece, J.; Srček, V. G.; Redovniković, I. R. Antimicrobial, cytotoxic and antioxidative evaluation of natural deep eutectic solvents. Environ. Sci. Pollut. Res. 2018, 25 (14), 1418814196,  DOI: 10.1007/s11356-018-1669-z
    63. 63
      Hou, C. T. New bioactive fatty acids. Asia Pac. J. Clin. Nutr. 2008, 17 (S1), 192195
    64. 64
      McKay, D. L.; Blumberg, J. B. A review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L.). Phytother. Res. 2006, 20 (8), 619633,  DOI: 10.1002/ptr.1936
    65. 65
      Muniyan, R.; Gurunathan, J. Lauric acid and myristic acid from Allium sativum inhibit the growth of Mycobacterium tuberculosis H37Ra: in silico analysis reveals possible binding to protein kinase B. Pharm. Biol. 2016, 54 (12), 28142821,  DOI: 10.1080/13880209.2016.1184691
    66. 66
      Barros, A. A.; Silva, J. M.; Craveiro, R.; Paiva, A.; Reis, R. L.; Duarte, A. R. C. Green solvents for enhanced impregnation processes in biomedicine. Current Opinion in Green and Sustainable Chemistry 2017, 5, 8287,  DOI: 10.1016/j.cogsc.2017.03.014
    67. 67
      Kitahara, T.; Koyama, N.; Matsuda, J.; Aoyama, Y.; Hirakata, Y.; Kamihira, S.; Kohno, S.; Nakashima, M.; Sasaki, H. Antimicrobial activity of saturated fatty acids and fatty amines against methicillin-resistant Staphylococcus aureus. Biol. Pharm. Bull. 2004, 27 (9), 13211326,  DOI: 10.1248/bpb.27.1321
    68. 68
      Ouattara, B.; Simard, R. E.; Holley, R. A.; Piette, G. J.-P.; Bégin, A. Antibacterial activity of selected fatty acids and essential oils against six meat spoilage organisms. Int. J. Food Microbiol. 1997, 37 (2–3), 155162,  DOI: 10.1016/S0168-1605(97)00070-6

Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

You’ve supercharged your research process with ACS and Mendeley!

STEP 1:
Click to create an ACS ID

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

OOPS

You have to login with your ACS ID befor you can login with your Mendeley account.

MENDELEY PAIRING EXPIRED
Your Mendeley pairing has expired. Please reconnect

This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. Read the ACS privacy policy.

CONTINUE